Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab
This study has been terminated.
( lack of enrollment )
Study NCT00287378   Information provided by The University of North Carolina, Chapel Hill
First Received: February 3, 2006   Last Updated: June 26, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Asthma
Allergy
Additional conditions recognized in this trial
Inflammation
More general conditions related to this trial
Pathologic Processes
Interventions listed in this trial
omalizumab
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Asthmatic Agents
Pharmacologic Actions
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
The University of North Carolina, Chapel Hill
National Institutes of Health (NIH)
Genentech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services